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Tuberous sclerosis complex (TSC) is a neurodevelop-
mental disease caused by TSC1 or TSC2 mutations
and subsequent activation of the mTORC1 kinase.
Upon mTORC1 activation, anabolic metabolism,
which requires mitochondria, is induced, yet at the
same time the principal pathway for mitochondrial
turnover, autophagy, is compromised. HowmTORC1
activation impacts mitochondrial turnover in neurons
remains unknown. Here, we demonstrate impaired
mitochondrial homeostasis in neuronal in vitro and
in vivo models of TSC. We find that Tsc1/2-deficient
neurons accumulate mitochondria in cell bodies, but
are depleted of axonal mitochondria, including those
supporting presynaptic sites. Axonal and global mi-
tophagy of damaged mitochondria is impaired, sug-
gesting that decreased turnover may act upstream
of impaired mitochondrial metabolism. Importantly,
blocking mTORC1 or inducing mTOR-independent
autophagy restores mitochondrial homeostasis. Our
study clarifies the complex relationship between the
TSC-mTORC1 pathway, autophagy, and mitophagy,
and defines mitochondrial homeostasis as a thera-
peutic target for TSC and related diseases.INTRODUCTION
Tuberous sclerosis complex (TSC) is a neurodevelopmental dis-
ease caused by loss-of-function mutations in the TSC1 or TSC2
gene and subsequent activation of the mTORC1 kinase (DiMario
et al., 2015; Lipton and Sahin, 2014). Although mTORC1
inhibitors have emerged as a therapy for certain disease mani-Cell Rep
This is an open access article under the CC BY-Nfestations, their impact on complex neurological manifestations
remains uncertain (https://clinicaltrials.gov/: NCT01289912,
NCT01730209, and NCT01954693). It is imperative to under-
stand the molecular mechanisms that result from loss-of-func-
tion mutations in TSC1/2 and that may promote intellectual
disability, seizures, or autism spectrum disorder in TSC.
Despite the fact that many TSC/mTORC1-related functions
have been extensively studied in non-neuronal cell types (Albert
and Hall, 2015), many remain unexplored in neuronal models of
TSC. Constitutive activation of mTORC1 has been shown to pro-
mote anabolic metabolism, while simultaneously repressing
catabolic processes such as autophagy. Mitochondria play a
crucial role in supporting anabolic metabolism, yet at the same
time, their function, maintenance, and turnover are tightly
regulated by autophagic flux. A central question thus remains
how TSC1/2 deficiency impacts mitochondrial homeostasis in
neurons.
In neurons, mitochondria form a highly dynamic reticular
network and undergo constant remodeling and turnover. To sup-
port local demands for mitochondrial ATP supply and calcium
buffering capacity, mitochondria are transported along microtu-
bule tracks to remote axonal regions (Maday et al., 2014), and
conversely dysfunctional mitochondria are returned to the cell
body for degradation (Cai et al., 2012). Maintenance of a func-
tional population of mitochondria is ensured through effective
autophagic degradation of aged and damaged mitochondria, a
process that has been termed mitophagy (Pickrell and Youle,
2015).
Neuropathological studies of mouse models of TSC and TSC
patients document impaired autophagic flux, and an accumula-
tion of organelles, including mitochondria (Di Nardo et al., 2014;
Goto et al., 2011; McMahon et al., 2012; Tang et al., 2014; Yasin
et al., 2013). The functional importance of the latter is corrobo-
rated by increased levels of oxidative stress in neuronal models
of TSC (Di Nardo et al., 2009; Tsai et al., 2012). Despite these
striking observations, however, relatively little is known aboutorts 17, 1053–1070, October 18, 2016 ª 2016 The Author(s). 1053
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the impact of TSC/mTORC1 on the turnover of neuronal
mitochondria.
Here, we investigate mitochondrial dynamics, metabolism,
and turnover in neuronal in vitro and in vivo models of TSC. We
find that Tsc1/2-deficient neurons progressively accumulate
mitochondria in cell bodies but are depleted of functional mito-
chondria in axons, including those that support presynaptic
sites. The dynamics of mitophagy are impaired both locally in
axons and globally across the neuron. Localizing the defect to
the late stages of the mitophagy pathway, we find that autopha-
gosome turnover is impaired. Finally, we find that either block-
ing mTORC1 or inducing mTOR-independent autophagy can
reverse changes in mitochondrial homeostasis seen in Tsc1/2-
deficient neurons. Collectively, these results provide evidence
for a previously unappreciated role of impaired neuronal mitoph-
agy in TSC. Addressing the role of mTORC1 in mitochondrial
turnover holds the promise for a better understanding of TSC
and the identification of therapeutic targets.
RESULTS
Mitochondria Accumulate inTsc2-DeficientNeurons but
Are Depleted from Axons
We hypothesized that Tsc2 deficiency induced mTORC1 activa-
tion might impact mitochondrial homeostasis. To address this,
we employed a flow cytometry-based assay (Mauro-Lizcano
et al., 2015) to quantitate mitochondrial content (Figure 1A).
We found that Tsc2-deficient neurons, with constitutive and sig-
nificant mTORC1 activation (Figure S1A; Choi et al., 2008), accu-
mulate mitochondria and show an increase in mitochondrial
mass to 2.5-fold the level of controls (Figures 1B and 1C).
This increase progresses even further as neurons mature in cul-
ture (Figure S1B), cannot be explained by an increase in cell size
alone (Figure S1C), and mimics that observed in giant cells of
Tsc1cc;Nes-rtTA+;TetOp-Cre+ (E16 doxy) mice (Goto et al.,
2011). Increasedmitochondrial mass can result from an increase
in mitochondrial biogenesis, a decrease in mitochondrial turn-
over, or both. Importantly, the transcription of critical mitochon-
drial biogenesis genes is not upregulated in Tsc2-deficient neu-
rons (Figure S1D). In fact, we observed no change in Pgc1a
expression and reduced expression levels of the Nrf1 and
mtTFA in Tsc2-knockdown neurons (Figure S1D). Levels of the
mtDNA-encoded COX-II were also reduced, whereas levels of
the nuclearDNA-encodedCOX-IVwere unchanged (FigureS1D).Figure 1. Tsc2-Deficient Neurons Accumulate Mitochondria in Their C
(A–C) Flow cytometry-based quantification of mitochondrial content using MT
mitochondrial content in cell bodies since neurites may be lost during sample p
samples).
(D) Live-cell confocal imaging of individual mitochondria in single axons of hippoca
5 mm.
(E) Distribution of mitochondria along the full length of axons in hippocampal neu
(F) Number of mitochondria per 100 mm of axon and the average length of ax
experiments).
(G–I) Quantitative assessment of mitochondrial morphology (circularity and Feret’
condition from 8–10 experiments). Scale bar, 10 mm.
(J and K) Transmission electronmicroscopy of callosal projection axons from Tsc1
number of mitochondria per micrograph and the average mitochondrial area (n >
Luc, Luciferase; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also FiguThese findings contrast with observations in non-neuronal cells
(Cunningham et al., 2007; Morita et al., 2013) and argue that
mitochondrial biogenesis is not increased in Tsc2-deficient
neurons.
To examine the distribution and dynamics of mitochondria, we
employed confocal live-cell imaging. Mitochondria in both con-
ditions form a dense network in the cell body, whereas they
sparsely populate axons (Figures 1D, 1E, and S1E). Consistent
with previous reports, we found that axon outgrowth is acceler-
ated in Tsc2-deficient neurons with an overall increase in axon
length (Figure 1F) and multiple axons frequently occurring
(Choi et al., 2008). Quantifying mitochondria along axons (Fig-
ure 1E), we found that Tsc2-deficient axons contain fewer mito-
chondria per 100 mm (Figure 1F), although their relative distribu-
tion follows a similar pattern to that of controls, with more
mitochondria in the proximal axon (Figure 1E). This finding sug-
gests that Tsc2-deficient axons are relatively depleted of mito-
chondria with the remaining mitochondria redistributing to cover
the full length of the axon.
Mitochondrial morphology changes are intimately linked to
mitochondrial dynamics and thus can serve as a surrogate
marker to screen for underlying abnormalities (Pernas and Scor-
rano, 2016). Small and circular mitochondria often indicate mito-
chondrial membrane depolarization and increased production of
reactive oxygen species. Axonal mitochondria in controls were
mostly tubular in shape and variable in size (Figures 1G–1I). In
contrast, Tsc2-deficient axons contained mitochondria that
were significantly smaller and displayed a more circular shape,
signifying mitochondrial fragmentation (Figures 1G and 1H).
The relative distribution of mitochondrial size revealed a left
shift in Tsc2-deficient neurons, indicating a greater proportion
of small, fragmented mitochondria (Figure 1I). Reintroducing
TSC2 was able to reverse changes in the morphology and num-
ber of axonal mitochondria, suggesting that these are indeed a
consequence of disturbed TSC-mTORC1 signaling (Figure S1F).
Further corroborating these findings in vivo using electronmicro-
scopy, we found that commissural axons of the corpus callosum
of Tsc1cc;Syn1Cre+ mice (Meikle et al., 2007) showed both a
reduced number of mitochondria and a decreased organelle
size (Figures 1J and 1K).
In summary, Tsc2-deficient neurons accumulatemitochondria
in their cell body but are relatively depleted of axonal mitochon-
dria with the remaining mitochondria showing an abnormal
morphology indicative of disrupted mitochondrial dynamics.ell Bodies but Are Depleted of Axonal Mitochondria
DR in cortical neurons (DIV11). Note that this assay primarily quantifies the
reparation (n = 9 3 106 recorded events per condition from nine independent
mpal neurons transduced with shLuc-GFP or shTsc2-GFP (DIV7/8). Scale bar,
rons (DIV7/8, n = 40 axons per condition from 8–10 experiments).
ons in hippocampal neurons (DIV7/8, n = 40 axons per condition from 8–10
s diameter) in axons of hippocampal neurons (DIV7/8, n > 400 mitochondria per
CC;Syn1Cre+ (n = 2) and Tsc1WW;Syn1Cre+ littermates (n = 3). Graphs show the
450 mitochondria per condition). Scale bar, 1 mm.
re S1.
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Figure 2. Mitochondrial respiration Is Impaired and Mitochondrial Membrane Potential, DJm, Is Diminished in Tsc2-Deficient Neurons and
Neurites of Human iPSC-Derived Cortical Neurons from TSC Patients
(A and B) Mitochondrial oxygen consumption rates in hippocampal neurons (DIV8) measured using the Seahorse XF Extracellular Flux 96 analyzer. Graphs show
different domains of mitochondrial function and non-mitochondrial respiration (n = 10 measurements per condition).
(legend continued on next page)
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Mitochondrial Respiration Is Impaired and
Mitochondrial Membrane Potential, DJm, Is Diminished
in Tsc2-Deficient Neurons and Mutant TSC2 Induced
Pluripotent Stem Cell-Derived Neurons
To investigate the effect of Tsc2 deficiency on mitochondrial
function, we measured oxygen consumption rates and the func-
tional parameters that can be derived from it (Figure S2A).
In Tsc2-deficient neurons, we found impaired mitochondrial bio-
energetics, evidenced by a reduction in baseline respiration,
ATP turnover, and total respiratory capacity (Figures 2A and
2B). This effect was specific to mitochondrial metabolism as
non-mitochondrial respiration and proton leak did not change
(Figure 2B).
An intact mitochondrial membrane potential (DJm) is a key
requisite for effective oxidative phosphorylation. To approximate
DJm, we used tetramethylrhodamine ethyl ester (TMRE), a
DJm-dependent dye. In Tsc2-deficient neurons, TMRE signal
was reduced (Figure 2C), reflecting a subset of mitochondria
that exhibit a decreased DJm. To localize mitochondria with a
diminished DJm, we employed the ratiometric DJm indicator,
JC-1 (Figure 2D). In control neurons, the vast majority of mito-
chondria show a high 600/530-nm ratio, indicating an intact
DJm (Figure 2D). In Tsc2-deficient neurons, we found a signifi-
cant shift toward a lower 600/530-nm ratio (Figure 2D), arguing
for a reduced electrochemical status in a significant subset.
Importantly, these mitochondria with diminished DJm were
readily detectable in neurites of Tsc2-deficient neurons (Fig-
ure 2D, white arrows). Expression analyses of electron transport
chain subunits revealed an increase of complex I (subunit
NDUFB8), a major site for reactive oxygen species production
(Murphy, 2009), and a decrease of complex II (subunit 30 kDa)
in Tsc2-deficient neurons (Figure S2B).
To test whether disease-specific mutations in patient-derived
cells share similar changes in mitochondrial function, we gener-
ated induced pluripotent stem cell (iPSC)-derived cortical neu-
rons (Zhang et al., 2013) from individuals with TSC and controls
(Table S1). We discovered that patient-derived neurons with a
heterozygous TSC2 mutation did not display detectable deficits
in mitochondrial respiration (Figures 2E and 2F). However, upon
introduction of a second loss-of-function mutation using tran-
scription activator-like effector nucleases (TALEN), we found a
marked reduction in mitochondrial function similar to that in rat
Tsc2-KD cortical neurons (Figures 2E and 2F). Next, we pulse-
labeled mitochondria with TMRE and MTDR (DJm independent)
and quantified the TMRE intensity in the soma and neurites (Fig-
ure 2G). TMRE signal in the soma was similar between TSC2+/(C) TMRE staining in hippocampal neurons (DIV7/8). Healthy mitochondria with
whereas dysfunctional mitochondria show reduced TMRE signal. Antimycin A (
confirming dynamic assay properties (n = 8 measurements per condition).
(D) JC1 staining in hippocampal neurons (DIV7/8). JC-1 accumulates in mitocho
centrations (emission, 530 nm) and forms aggregates at higher concentrations (e
Arrows denote mitochondria with low DJm (n = 6 experiments).
(E and F) Mitochondrial oxygen consumption rates in iPSC-derived cortical neuro
same cell line with a second, engineered TSC2mutation leading to a complete lo
Table S1). Graphs show different domains of mitochondrial function and non-mi
(G and H) TMRE and JC1 staining in iPSC-derived cortical neurons (summarized i
condition from 3 experiments; JC1: n > 85 mitochondria per condition from 3 ex
het, heterozygous; hom, homozygous; MT, MitoTracker. *p < 0.05, **p < 0.01, **iPSC-derived neurons and controls, but reduced in homozygous
mutants (Figure 2G). The TMRE signal in neurites was overall
weaker than that in the soma, likely reflecting the high density
of mitochondria in the latter (Figure 2G). Compared to controls,
neurites of TSC2+/ and TSC2/ iPSC-derived cortical neurons
contained many mitochondria with a low TMRE fluorescence,
although they retained their MitoTracker Deep Red (MTDR)
signal (Figure 2G, arrows), suggesting an accumulation of depo-
larized mitochondria. This was confirmed using the JC1 assay
(Figure 2H, arrows). Notably, we detected mTORC1 activation
in TSC2+/ iPSC-derived neurons (M-J.H. andM.S., unpublished
data), similar to recently published observations of mTORC1
hyperfunction in TSC2+/ human embryonic stem cell-derived
neurons (Costa et al., 2016).
Taken together, these findings suggest that multiple domains
of mitochondrial bioenergetics are compromised in both Tsc2-
deficient rodent neurons and TSC patient-derived neurons
in vitro.
Axonal Mitochondria in Tsc2-Deficient Neurons Are
Shuttled to the Cell Body Leading to a Depletion of
Presynaptic Mitochondria
Neurons are unique in their architecture with critical compart-
ments, such as axons and synapses, located far from the cell
body. In Tsc2-deficient neurons, we observed increased mito-
chondrial mass in the cell body but mitochondrial depletion
from axons (Figures 1C and 1F), arguing for a redistribution of
axonal mitochondria. To examine axonal transport in Tsc2-defi-
cient neurons, we selected a mid-axonal segment, 500–800 mm
from the cell body, to avoid regional differences in mitochondrial
transport (Figures 3A and S3A; Movies S1 and S2). Consistent
with previous reports in similar assays (Pekkurnaz et al., 2014;
Wang and Schwarz, 2009), mitochondria in control neurons are
stationary in80%–85% of the time and are moving bidirection-
ally15%–20% of the time (Figures 3A and 3B). Strikingly, mito-
chondria in Tsc2-deficient neurons spend less time in a station-
ary position and instead display markedly enhanced retrograde
transport (Figures 3A and 3B).
Axonal mitochondria undergo dynamic transport, and motile
mitochondria often pause and move again in response to phys-
iological changes. We found that mitochondria in Tsc2-deficient
axons exhibitedmore stops andmore frequent changes in direc-
tion (Figure 3C). Examining the kymographic morphology, we
discovered that a subset of mitochondria in Tsc2-deficient axons
showed a peculiar oscillating movement pattern, moving back
and forth without any significant net displacement (Figure 3A,an intact DJm accumulate TMRE, thus displaying high TMRE fluorescence,
40 mM, 1 hr), a complex III inhibitor, leads to a rapid breakdown of the DJm,
ndria in a DJm-dependent manner, where it exists as monomers at low con-
mission, 600 nm). Representative confocal images of mitochondria in neurites.
ns from a TSC patient with a heterozygous TSC2mutation (mutTSC2 [het]); the
ss of TSC2 (mutTSC2 [hom]); and a healthy related donor (Ctrl) (summarized in
tochondrial respiration (n = 6 measurements per condition).
n Table S1). Arrows denote mitochondria with low DJm (TMRE: n > 35 cells per
periments).
*p < 0.001, ****p < 0.0001. See also Figure S2.
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red arrows). Although 2% of mitochondria in control neurons
showed this pattern, this rate was increased to 9% in Tsc2-
deficient neurons (Figure 3D). A similar oscillating pattern has
been recently reported in axonal mitochondria of PINK1 or
Parkin overexpressing Drosophila melanogaster (Devireddy
et al., 2015), potentially linking it to incipient mitophagy.
No change in the axonal transport pattern of other cargo,
such as lysosomes, was observed, arguing that the effect of
Tsc2 deficiency on mitochondria is relatively specific (Fig-
ure S3B). Overexpression of the anchoring protein syntaphilin
almost completely arrested mitochondrial transport, confirming
that general mechanisms of axonal transport and anchoring
are intact (Figure S3C).
Since we observed an accumulation of mitochondria with
low DJm in Tsc2-deficient neurites, we hypothesized that these
potentially damaged mitochondria might be successively re-
turned to the cell body, as previously suggested (Cai et al.,
2012). Indeed, mitochondria transported in the retrograde direc-
tion displayed a reduced TMRE fluorescence in both control
and Tsc2-deficient axons (Figures 3E and 3F), indicating that
dysfunctional mitochondria are preferentially returned to the
cell body.
Stationary mitochondria are enriched at presynaptic sites
where they supply ATP and buffer calcium, functions that are
critical for synaptic vesicle release. Similarly, motile mitochon-
dria passing through presynaptic boutons can dynamically influ-
ence synaptic transmission (Sun et al., 2013). We hypothesized
that increased retrograde transport and depletion of axonal
mitochondria in Tsc2-deficient neuronsmight influence the avail-
ability of mitochondria to synapses. To investigate the presynap-
tic capturing of mitochondria, we performed dual-channel time-
lapse confocal microscopy in axons of neurons transfected with
mito-DsRed and VGLUT1-Venus at days in vitro 7/8 (DIV7/8)
(Figure 3G) and DIV14/15 (Figure S3D) as described previously
(Courchet et al., 2013). Tsc2 downregulation did not affect the
density of stable VGLUT1-Venus puncta (Figure 3H). However,
quantifying the number of stable presynaptic sites that contain
stationary mitochondria, we discovered a 50% reduction
of mitochondria captured at presynaptic sites (Figure 3H). We
also observed thatmotile mitochondria frequently dwell over sta-
ble VGLUT1 puncta in control axons (Figure 3I). In contrast, in
Tsc2-deficient axons, we found a decrease in the time thatmotile
mitochondria spend over stable VGLUT1-postive presynaptic
sites, whereas the dwell time outside the presynaptic compart-Figure 3. Axonal Mitochondria in Tsc2-Deficient Neurons Are Shuttle
Impaired
(A) Mitochondrial transport quantified through a standardized live-cell microscop
(B and C) Mitochondrial transport in the mid-axon of hippocampal neurons (DIV7
moving in the retrograde or anterograde direction. The frequency of stops and ch
from 5–8 experiments).
(D) Percentage of axonal mitochondria with an oscillating movement pattern (n >
(E and F) TMRE staining in stationary mitochondria versus mitochondria transport
(G) Quantitative assessment of mitochondrial capturing at presynaptic sites and
(H) Number of stable presynaptic puncta per 100-mm axon and the percentage
campal neurons (DIV7/8, n = 14 axons per condition from 7 experiments).
(I) Average dwell time of motile mitochondria at and outside of stable presynapt
experiments).
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure S3.ment did not differ from controls (Figure 3I). In more mature
neurons at DIV14/15, most axonal mitochondria maintain a
stationary position (Figure S3D). Looking at the number of sta-
tionary mitochondria captured at presynaptic sites, we found
that mature Tsc2-deficient axons contained fewer synapses
that are supported by local stationary mitochondria (Figure S3E).
Hence, presynaptic capture of mitochondria is diminished
in both developing and more mature Tsc2-deficient neurons
in vitro.
Collectively, these experiments reveal enhanced retrograde
transport of dysfunctional mitochondria as a potential mecha-
nism that depletes axonal mitochondria in Tsc2-deficient neu-
rons. Importantly, the availability of mitochondria to presynaptic
sites is compromised arguing for insufficient mitochondrial
capture.
Spatiotemporal Dynamics of Local Mitophagy Are
Impaired in Axons of Tsc2-Deficient Neurons
The above experiments indicate alterations in mitochondrial
mass, dynamics, and function that suggest impairment of mito-
chondrial turnover. Mitochondrial turnover via mitophagy occurs
both locally in axons (Ashrafi et al., 2014) and in the soma (Cai
et al., 2012). Might changes inmitophagy help explain decreased
mitochondrial turnover? To address this question, we investi-
gated both axonal mitophagy and global mitophagic flux.
To stimulate mitophagy in axons (Figure 4A), we employed
treatment with antimycin A, which leads to a rapid loss of DJm
(Figure S4A), thus allowing us to investigate mitophagic events
in a time frame amenable to live-cell imaging without impairing
axonal integrity (Ashrafi et al., 2014) (Figure S4B). Consistent
with previous studies (Wang et al., 2011), we found that acute
DJm depolarization renders most axonal mitochondria station-
ary (Figure S4C; Movie S3), and induces rapid fragmentation
(Figures 4B and S4D), which may precede mitophagy. We
approximated the rates of early mitophagy in axons by quanti-
fying the percentage of Venus-LC3 puncta that co-localize with
mitochondria following DJm depolarization (Klionsky et al.,
2016). At baseline, Venus-LC3 is mostly cytosolic and only a
small fraction of Venus-LC3 vesicles co-localize with mitochon-
dria (Figures 4C and 4D). In response to DJm depolarization,
however, we observed accumulation of Venus-LC3 on mito-
chondria with 20% of mitochondria becoming coated with
LC3 in control neurons (Figure 4D). In contrast, we observed a
blunted mitophagic response in Tsc2-deficient neurons withd to the Cell Body and Presynaptic Capturing of Mitochondria Is
y assay (see Figure S3A).
/8). Graph shows the time that mitochondria spend in a stationary position, or
anges in direction per 5-min recording is calculated (n > 25 axons per condition
25 axons per condition from 5–8 experiments).
ed in the retrograde direction (n > 10 axons per condition from 3 experiments).
representative examples (DIV7/8).
of stable presynaptic puncta supported by stationary mitochondria in hippo-
ic puncta in hippocampal neurons (DIV7/8, n = 14 axons per condition from 7
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Figure 4. Spatiotemporal Dynamics of Axonal Mitophagy Are Impaired in Tsc2-Deficient Neurons
(A) Schematic showing the sequence of events during mitophagy.
(B) Morphology of axonal mitochondria before and after acute DJm depolarization with antimycin A (40 mM, n > 140 mitochondria per condition from 5 ex-
periments). Scale bar, 5 mm.
(C and D) Recruitment of autophagosomes to axonal mitochondria following acute DJm depolarization with antimycin A (40 mM). Arrows denote mito-dsRed-
labeled mitochondria (red), Venus-LC3-labeled autophagosomes (white), and their co-localization (yellow). Graph shows the maximal percentage of mito-
chondria co-localizing with autophagosomes in individual axons (n > 40 axons per condition from 12 experiments). Scale bar, 10 mm.
(legend continued on next page)
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only a small proportion of mitochondria co-localizing with Venus-
LC3 vesicles (Figure 4D). These data suggest that Tsc2 defi-
ciency results in impaired spatiotemporal dynamics of local
mitophagy in axons.
Autophagic degradation of mitochondria is a multistep
pathway (Figure 4A). To examine the late stages, we quantified
the autophagic delivery of mitochondria to lysosomes. At base-
line, we observed lysosomes in axons, a portion of which
co-localized with mitochondria (Figures 4E and 4F). Following
mitophagy induction, we found a significant increase in the
co-localization of lysosomes with mitochondria in control neu-
rons. In Tsc2-deficient neurons, however, we could not detect
a similar increase (Figures 4E and 4F).
Taken together, these results reveal impaired recruitment of
autophagosomes and lysosomes to damaged axonal mitochon-
dria in Tsc2-deficient neurons, although some degree of early
mitophagy is retained.
Global Mitophagic Flux Is Impaired in Tsc2-Deficient
Neurons
Mitophagy has been well characterized in the cell body of neu-
rons, where the majority of mature, acidic lysosomes reside
(Johnson et al., 2016). To examine baseline steady-state
levels of mitophagy, we purified mitochondria-enriched frac-
tions from Tsc2-deficient neurons and controls as previously
described (Figures 5A and S5A; Narendra et al., 2010). Levels
of the autophagy markers LC3-II and p62 (Figures 5B and 5C)
were robustly increased both in the cytosol and in mitochon-
dria-enriched fractions from Tsc2-deficient neurons relative to
controls, indicating an accumulation of autophagosomes and
autophagy substrates. Measuring levels of PINK1 and Parkin,
two proteins involved in mitophagy (Pickrell and Youle, 2015),
we found that both were enriched in mitochondrial fractions
of Tsc2-deficient neurons, potentially reflecting mitochondrial
damage and early mitophagic events (Figures 5D and 5E).
The above experiments allow us to investigate the early steps
of mitophagy but do not assess the net flux through the pathway.
To investigate mitophagic flux, we employed flow cytometry
(Figure 5F). We inducedmitophagy by depolarizingmitochondria
with a low dose of carbonyl cyanide m-chlorophenyl hydrazone
(CCCP), a compound that dissipates the DJm (Mauro-Lizcano
et al., 2015). Mitochondrial mass was determined by staining
with the DJm-independent mitochondrial dye MTDR (Fig-
ure 5F–5H). In control neurons, 24 hr of CCCP led to a reduction
of 10% of MTDR fluorescence relative to untreated cells (Fig-
ure 5G), indicating that depolarized mitochondria are degraded
efficiently. As expected, co-treatment with saturating concentra-
tions of bafilomycin A1, a compound that blocks autophago-
some-lysosome fusion (Klionsky et al., 2016), prevented this
decrease (Figure S5B). In Tsc2-deficient neurons treated with
CCCP, no significant mitochondrial degradation was observed
(Figure 5H). Together, these findings indicate a block of global
mitophagic flux in Tsc2-deficient neurons.(E and F) Recruitment of lysosomes to axonal mitochondria following acute DJm
mitochondria (red), LysoTracker Green-labeled lysosomes (white), and their co-lo
localizing with lysosomes in individual axons (n > 25 axons per condition from 8
AU, arbitrary unit; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also FigUpon mitochondrial damage, the ubiquitin ligase Parkin is re-
cruited to ubiquitinate mitochondrial proteins. This attracts ubiq-
uitin-binding proteins such asp62,which are believed to facilitate
the recruitment of LC3-positive autophagosomes (Figure 4A).
Clearance of damaged mitochondria also removes these modifi-
cations. Paralleling our studies of mitochondrial flux, we exam-
ined the presence of Parkin, ubiquitinated proteins, and LC3 in
mitochondrial fractions of Tsc2-deficient neurons and controls
treated with CCCP (Figures 5I–5K). Polyubiquitinated proteins
accumulated in mitochondrial fractions following CCCP treat-
ment with a marked and sustained increase in Tsc2-deficient
neurons (Figures 5I and 5J). Levels of Parkin and p62 were simi-
larly increased at baseline and remained high following CCCP
indicating the continued presence of early mitophagy surrogates
in Tsc2-deficient neurons (Figures 5I and 5J). Measuring levels of
lipidated LC3 (LC3-II), we discovered that it was enriched inmito-
chondrial fractions of Tsc2-deficient neurons both at baseline
and after CCCP treatment, reflecting increased amounts of un-
processed autophagosomes (Figures 5I and 5K).
Collectively, these findings demonstrate impaired global mito-
phagic flux following mitochondrial damage in Tsc2-deficient
neurons. Our findings point to a block downstream of autopha-
gosome recruitment with proteins involved in early mitophagy
and autophagosomes accumulating within mitochondrial frac-
tions of Tsc2-deficient neurons.
Deficits in Lysosome-Dependent Stages of Mitophagy
To better understand the block inmitophagic flux downstream of
autophagosome recruitment, we analyzed the dynamics of auto-
phagosome formation and recruitment in response to a stimulus
that triggers mitophagy. We treated neurons with antimycin A
and followed the formation and turnover of LC3-Venus-labeled
autophagic vesicles using live-cell confocal imaging (Figure 6A;
Movies S4 and S5). At baseline, control cells carry several small
LC3-Venus dots or crescent-shaped puncta representing
nascent or maturing autophagosomes that are mostly outside
of mitochondria-dense areas (Figure 6A). In Tsc2-deficient neu-
rons, LC3-Venus is present in fine dot-like vesicles that are
observed to partly overlap with mitochondria but also in large ve-
sicular structures that appear in no spatial relationship with mito-
chondria (Figure 6A). Following induction of mitophagy, control
cells rapidly form LC3-positive puncta and show autophagic
turnover (Figures 6A–6C). In Tsc2-deficient neurons, new LC3-
positive vesicles form, but stay relatively small and importantly
do not seem to engage in fusion with preexisting large LC3-ves-
icles, therefore leading to no net increase in mean autophago-
some size (Figures 6A–6C). Interestingly, no turnover of newly
formed LC3 puncta is appreciated during the course of these
live-cell imaging experiments, indicating delayed and/or dimin-
ished autophagosome maturation or autophagosome-lysosome
fusion in Tsc2-deficient cells (Figures 6A and 6B).
To probe autophagosome-lysosome fusion following mitoph-
agy induction, we employed the mCherry-GFP-LC3 tandemdepolarization with antimycin A (40 mM). Arrows denote mito-dsRed-labeled
calization (yellow). Graph shows the maximal percentage of mitochondria co-
experiments). Scale bar, 5 mm.
ure S4.
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assay (Kimura et al., 2007), which allows distinguishing autopha-
gosomes before and after fusion with acidic lysosomes (Fig-
ure S5C; Klionsky et al., 2016). Following mitophagy induction,
we discovered that nascent autophagosomes mature and to a
certain extend are converted to autolysosomes (Figure 6D). In
the Tsc2-deficient neurons, we did not observe such a recruit-
ment of autolysosomes (Figure 6D). Instead, these vesicles re-
mained at the stage of autophagosomes, further underscoring
a block in the late stages of mitochondrial-damage-induced
autophagy.
Reduced availability of mature lysosomes may be a rate-
limiting factor for autophagosome-lysosome fusion. To quantify
the pool of mature lysosomes available for fusion events, we em-
ployed an automated confocal microscopy approach to deter-
mine the amount of LysoTracker–stained lysosomes in a large
number of Tsc2-deficient neurons and controls (Figure 6E).
Indeed, a smaller area was covered with lysosomal vesicles in
Tsc2-deficient neurons (Figure 6E), indicating fewer lysosomes
available for fusion.
The Impact of mTOR-Dependent and
mTOR-Independent Stimulation of Autophagy on
Mitochondrial Dynamics, Turnover, and Function
The above experiments demonstrate that mitophagic flux in
Tsc2-deficient neurons is impaired at the autophagosome
recruitment stage and/or downstream lysosome-dependent
stages. To test whether mTOR-dependent or mTOR-indepen-
dent mechanisms are able to overcome or bypass this block in
mitophagic flux,we treatedneuronswith rapamycin (mTORC1 in-
hibitor, mTOR-dependent enhancer of autophagy; Ravikumar
et al., 2002), and carbamazepine (mTOR-independent enhancer
of autophagic flux;Maetzel et al., 2014).We found that both treat-
ments engaged the formation of LC3-II and reduced levels of the
autophagy substrate p62, confirming that autophagic flux is
induced (Figure S6A). Quantifying global mitophagic flux, we
discovered that acute inhibition of mTORC1 with rapamycin did
not induce a substantial turnover of mitochondria in Tsc2-defi-
cient neurons (Figure 7A). Carbamazepine, however, robustly
reduced mitochondrial content in Tsc2-deficient neurons to
about 85%of that of vehicle-treated controls (Figure 7A). Probing
the recruitment of autophagosomes to axonal mitochondria, we
found that both treatments stimulated the recruitment of LC3-
positive autophagosomes to damagedmitochondria (Figure 7B).
Interestingly both treatments also increased co-localization of
autophagosomeswithmitochondria at baseline, without an addi-
tionalmitophagic stimulus (Figure7B). This could indicate that ex-
isting damaged mitochondria are targeted when autophagic flux
is stimulated. In line with the data on global mitophagic flux, car-
bamazepine showed a particularly strong effect in Tsc2-deficientFigure 5. Global Mitophagic Flux Is Impaired in Tsc2-Deficient Neuron
(A–E) Representative western blots and quantification of several proteins involve
neurons (DIV7/8, n = 12 experiments).
(F–H) Mitophagic flux induced by CCCP (1 mM, 24 hr) quantified using flow cytome
(I–K) Western blotting for several proteins involved in mitophagy in cytosolic an
CCCP (1 mM, 24 hr) or vehicle (n = 3–6 experiments).
C, Cyto, cytosolic fraction; HMW, high molecular weight; M, Mito, mitochondr
****p < 0.0001. See also Figure S5.axons (Figure 7B). Combining rapamycin and carbamazepine
had no additive effect, suggesting that each treatment alone
may achieve saturating levels of autophagy induction in axons.
To test the relevance of these findings for neurons in vivo, we
treated Tsc1cc;Syn1Cre+ mice with rapamycin and prepared
mitochondria-enriched fractions from cortex. Mitochondrial
fractions of Tsc1cc;Syn1Cre+ mice accumulate LC3 and p62,
both of which were reduced in rapamycin-treated mice (Figures
7C and 7D). Levels of Parkin and of the mitochondrial marker
Tomm20 were also reduced following rapamycin treatment,
suggesting that Tsc1cc;Syn1Cre+ mice can effectively prevent
or clear mitochondria targeted for mitophagy once mTORC1
signaling is inhibited and autophagic flux is engaged as evidence
by an increased cytosolic LC3II/LC3I ratio (Figures 7C and S6B).
Does a correction of axonal mitophagy replenish axons with
mitochondria? To address this question, we determined the
number of mitochondria per axon area in cultured Tsc2-deficient
neurons and callosal axons of Tsc1cc;Syn1Cre+ mice. In vitro,
rapamycin and carbamazepine significantly increased the num-
ber of axonal mitochondria to levels that either did not differ from
or surpassed controls (Figure 7E). In vivo, chronic treatment of
Tsc1cc;Syn1Cre+mice with rapamycin also normalized the num-
ber of mitochondria in callosal axons to levels that are similar to
those in control littermates (Figure 7F). In addition to local turn-
over, influx of new mitochondria from the cell body and mecha-
nisms that promote their peripheral anchoring determine the
availability of mitochondria to distal axonal regions. Examining
transport patterns of axonal mitochondria, we discovered that
rapamycin and carbamazepine promoted the time that these
spend in a stationary position at the expense of the increased
retrograde transport observed in Tsc2-deficient neurons without
treatment (Figures 7G–7I). Rapamycin particularly promoted
their anterograde transport (Figure 7G), perhaps leading to an
even greater replenishment of axonal mitochondria (Figure 7E).
To explore the functional consequences of correcting
local mitochondrial turnover and transport, we quantified the
capturing of mitochondria at presynaptic sites (Figures 7H and
7I). Although both treatments and their combination did not influ-
ence the overall number of presynaptic sites, they led to an in-
crease in the proportion of presynaptic sites that are supported
by stationary mitochondria (Figure 7H). Likewise, the dwell time
of motile mitochondria at presynaptic sites increased to levels
that were similar to those in control axons (Figure 7I). Arguing
for an increased anchoring specifically at presynaptic sites,
the dwell time outside of presynaptic compartments remained
unchanged (Figure 7I).
In summary, these data suggest that suppressing mTORC1
hyperactivity or inducing mTOR-independent autophagy can
reverse many of the changes in mitochondrial dynamics ands
d in mitophagy in cytosolic and mitochondria-enriched fractions from cortical
try in cortical neurons (DIV11, n = 63 106 recorded events from 6 experiments).
d mitochondria-enriched fractions from cortical neurons (DIV7/8) treated with
ia-enriched fraction; mono, monomeric; *p < 0.05, **p < 0.01, ***p < 0.001,
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turnover seen in Tsc2-deficient neurons. Chronic treatment with
rapamycin or carbamazepine for 7 days also improved DJm
(Figure S6C), whereas short-term treatment did not (Figure S6D).
This dependence on chronic treatment argues that a complete
restoration of mitochondrial function is only achieved when
several stages of mitochondrial dynamics are intact for a pro-
longed time period.
DISCUSSION
Mitochondria are critical to many neuronal functions and their
dynamics and turnover are tightly regulated. Autophagy is the
principal pathway that clears damaged, aged, and superfluous
mitochondria (Pickrell and Youle, 2015). Previous work has
shown that autophagy is significantly impaired in TSC-deficient
cells and tissues (Di Nardo et al., 2014; McMahon et al., 2012;
Parkhitko et al., 2011; Tang et al., 2014; Yasin et al., 2013). Iden-
tifying specific deficits downstream of mTORC1 and autophagy
dysfunction may reveal more precise targets for therapeutic in-
terventions. Mitochondria are substrates of autophagy but also
essential for mTOR-hyperactivity-induced anabolism; thus, it is
important to understand how TSC deficiency impacts mitochon-
drial homeostasis in neurons.
Here, we address this question through a characterization of
mitochondrial turnover and dynamics in neuronal in vitro and
in vivo models of TSC. Using multiple approaches, we identified
deficits in global and local mitophagy in Tsc2-deficient neurons
and downstream accumulation of mitochondria, with at least a
subset of organelles being defective. Importantly, we find that
these changes in mitochondrial turnover affect the dynamics
and integrity of axonal mitochondria leading to a depletion of
functional mitochondria from presynaptic sites.
Mitophagy and Mitochondrial Fragmentation in TSC
The mitochondrial content in any given cell and their mainte-
nance are subject to a complex interplay between mitochondrial
biogenesis and degradation. In dividing, non-neuronal cells, loss
of TSC2 leads to an increase in mitochondrial mass (Koyanagi
et al., 2011; Morita et al., 2013) that is accompanied by an in-
crease in the transcription of genes associated with mitochon-
drial biogenesis (Cunningham et al., 2007). In Tsc2-deficient
neurons, we discovered an increased mitochondrial mass that
seems to progress with maturation in vitro but were unable to
identify an increase in mRNA levels of the core mitochondrial
biogenesis genes, Pgc1a, Nrf-1, and mTFAM. Therefore,
increased biogenesis is not likely to drive the increased mito-
chondrial mass observed in Tsc2-deficient neurons.
When mitochondria are excessively abundant, damaged, or
aged, mitophagy is engaged to restore homeostasis. MitophagyFigure 6. Deficits in the Lysosome-Dependent Stages of Mitophagy in
(A–C) Autophagosome turnover in hippocampal neurons (DIV7/8) acutely treated
number and size from baseline (n = 3 experiments). Scale bar, 10 mm, 5 mm (inse
(D) Autophagosomes (GFP+ and mCherry+) and autolysosomes (RFP+only) in hip
treated with antimycin A (40 mM; n = 4 experiments).
(E) LysoTracker Deep Red-stained lysosomes in hippocampal neurons (DIV7/8).
(n > 25 3 103 cells per condition from 3 experiments). Scale bar, 40 mm.
***p < 0.001, ****p < 0.0001. See also Figure S5.undergoes several stages and relies on the general autophagy
program to clear mitochondria via engulfment by autophagic
vesicles and finally degradation in autolysosomes, the product
of mature autophagosomes and lysosomes (Figure 4A). In
Tsc2-deficient neurons, we discovered a reduction in CCCP-
induced mitophagic flux and an accumulation of proteins
involved in the early steps of mitophagy, such as PINK1 and Par-
kin, in mitochondrial preparations. Similarly, we found abundant
levels of p62, a stress-induced ubiquitin-binding protein, that,
in addition to other functions, may be acting as a selective recep-
tor for targeting damaged mitochondria to autophagosomes
(Okatsu et al., 2010) and is commonly found in protein aggre-
gates that result from autophagy impairment (Komatsu et al.,
2007). We observed abundant levels of the autophagosome
marker LC3-II in mitochondria-enriched fractions of Tsc2-
deficient neurons, with no significant change after stimulation
of mitophagy with CCCP. These results suggest that proteins
involved in the early steps ofmitophagy accumulate in Tsc2-defi-
cient neurons. Although mitophagy is engaged following the
introduction of mitochondrial damage, it does not progress to
the degradation of mitochondria and no net loss of mitochondria
can be detected. Pointing to a block in the late stages of the
autophagy pathway, autophagosome maturation into autolyso-
somes following mitophagy induction was impaired. Levels of ly-
sosomes were reduced in Tsc2-deficient neurons, suggesting
that the pool of mature lysosomes available for fusion with auto-
phagosomes may be limited.
Mitochondrial morphology mirrors changes in turnover and
function and can thus serve as a surrogate for both. Mitochon-
drial fragmentation is found in many forms of mtDNA diseases
with reduced oxidative phosphorylation, where it is thought to
segregate mitochondria containing deleterious mutations and
may promote their degradation through autophagy (Pryde
et al., 2016; Twig et al., 2008). In Tsc1/2-deficient neurons, we
discovered a reduction of the average size of axonal mitochon-
dria both in vitro and in vivo. We further found an increase in
the circularity of axonal mitochondria, pointing to ongoing mito-
chondrial fragmentation reflecting dysfunction and perhaps
ensuing turnover.
Axonal and Presynaptic Mitochondria in TSC
Intellectual disability, seizures, and autism spectrum disorder
in many patients with TSC may at least in part originate from
synaptic dysfunction (Sahin and Sur, 2015). Underscoring the
importance of axonal mitochondria in this process, removing
mitochondria from axon terminals has been shown to result in
aberrant synaptic transmission (Ma et al., 2009; Verstreken
et al., 2005). Mitochondrial dysfunction, reactive oxygen
species, and a reduced availability of functional mitochondriaTsc2-Deficient Neurons
with antimycin A (40 mM). Graphs show the percent change in autophagosome
t).
pocampal neurons (DIV7/8) transfected with mCherry-EGFP-LC3 and acutely
Graph shows the lysosomal area as a percentage of the GFP-stained cell area
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to synapses, as a result of impaired mitophagy, may critically
impair synaptic function (Haddad et al., 2013; Santini et al., 2015).
Axonal mitochondria are subject to active transportation
(Sheng, 2014) and local turnover (Ashrafi et al., 2014). We
explored both in Tsc2-deficient neurons. Mitochondria were
relatively depleted from Tsc2-deficient axons, which may be
partly explained by an increased retrograde transportation of
mostly damaged mitochondria. Damaged mitochondria were
frequently observed and may be a result of impaired local turn-
over through mitophagy. In light of these findings, we speculate
that reduced axonal mitophagy may lead to a buildup of
damaged mitochondria over time. This buildup is met with
increased retrograde transportation to clear dysfunctional and
potentially harmful organelles from vulnerable, distal regions
and perhaps leads to their clustering in the cell body where lyso-
somes are relatively enriched. The net effect of this is a depletion
of axonal mitochondria.
Because of great regional differences in demand for ATP sup-
ply and calcium buffering, axonal mitochondria are transported
bidirectionally and anchored as needed, particularly at active
sites such as synapses (Rangaraju et al., 2014). To probe the
availability of mitochondria to synapses, we investigated presyn-
aptic capturing of mitochondria in developing and more mature
axons. We discovered that presynaptic sites in Tsc2-deficient
neurons were deprived of stationary mitochondria. In addition,
we found that motile mitochondria, known to provide their func-
tion to presynaptic compartments en passant, spend less time
dwelling over presynaptic sites. The reduced availability of mito-
chondria at synapses may bear importance to altered neuronal
connectivity, intellectual disability, and seizures in TSC.
Correcting Deficits in Mitochondrial Homeostasis
in TSC
mTOR inhibitors have been shown to correct many molecular
and behavioral deficits in neuronal models of TSC. This has
paved the way for randomized placebo-controlled trials of
mTOR inhibitors for neurocognitive deficits in children with
TSC (Ebrahimi-Fakhari and Sahin, 2015). Autophagy can be acti-
vated in an mTORC1-dependent manner or by mechanisms thatFigure 7. The Impact of mTOR-Dependent and mTOR-Independent S
Function
(A) Quantification of mitophagic flux using flow cytometry in cortical neurons (DI
n = 3 3 106 recorded events per condition from 3–6 experiments).
(B) Recruitment of Venus-LC3-labeled autophagosomes to axonal mitochondria
neurons (DIV7/8) pretreated with rapamycin, carbamazepine, or a combination o
(C and D) Western blotting for several proteins involved in mitophagy in cytoso
(n = 8), Tsc1CC;Syn1Cre+ mice treated with rapamycin (n = 4), and Tsc1ww;Syn1C
(E) Number of mitochondria per 100-mmaxon in hippocampal neurons (DIV 7/8) pr
experiments).
(F) Number of mitochondria in callosal projection axons from Tsc1cc;Syn1Cre
Tsc1ww;Syn1Cre+ littermate controls (n = 3, P21) using transmission electron mic
(G) Mitochondrial transport in the mid-axon of hippocampal neurons (DIV7/8) pret
experiments).
(H) Number of stable presynaptic puncta per 100-mm axon and the percentage of
(DIV7/8) pretreatedwith rapamycin (20 nM, 24 hr), carbamazepine (100 mM, 24 hr),
(I) Dwell time ofmotilemitochondria at and outside of stable presynaptic puncta in
combination of both drugs (n = 14 axons per condition from 7 experiments).
Cyto, cytosolic fraction; Mito, mitochondrial fraction; ns, not significant; *p < 0.0do not rely on mTOR kinase activity (Ebrahimi-Fakhari et al.,
2014, 2016). To assesswhether enhancing autophagy could cor-
rect mitochondrial deficits in Tsc2-deficient neurons, we treated
them with rapamycin and carbamazepine. The latter is a widely
used anticonvulsive drug that is thought to engage autophagy
through reducing free inositol and myoinositiol-1,4,5-triphos-
phate levels (Sarkar et al., 2005; Schiebler et al., 2014). Both
treatments corrected multiple deficits and importantly replen-
ished axonal mitochondria, including those that support presyn-
aptic sites. Our data thus indicate that induction of autophagy
itself is beneficial and suggest that both compounds can restore
the clearance of damaged mitochondria. This also implies that,
once autophagy deficits are bypassed, lysosomal proteolysis
is functional in Tsc2-deficient neurons. These experiments also
indicate that the deficits in lysosome-dependent stages of mi-
tophagy still enable some increased substrate flux upon induc-
tion of autophagosome biogenesis, suggesting that the principal
defect in mitochondrial turnover in Tsc2-deficient neurons
results from a compromise of the autophagy-lysosomal pathway
and is not primarily caused by impairment of early mitophagy
events such as PINK1 or Parkin signaling. The fact that
combining both treatments did not have an additive effect sug-
gests that autophagy, rather than other downstream targets of
mTORC1 signaling, is likely the main contributor to the restora-
tion of mitochondrial phenotypes in Tsc2-deficient neurons,
with either treatment alone achieving saturated levels of auto-
phagy induction.
Our findings lend support to the concept that promoting clear-
ance of damaged mitochondria through engaging autophagic
flux by mTOR-dependent and -independent mechanisms has
potential therapeutic value for neurological diseases with mito-
chondrial dysfunction. Along these lines, rapamycin has been
successfully used to drive selection against pathogenic mtDNA
mutations in models of mtDNA diseases (Dai et al., 2014; John-
son et al., 2013). We acknowledge, however, that even though
we probe mTORC1-dependent and independent mechanisms
to bypass autophagy deficits, future studies will need to fully
dissect the role of mTORC1 inhibition in restoring mitochondrial
deficits beyond correction of mitochondrial turnover (Johnsontimulation of Autophagy on Mitochondrial Dynamics, Turnover, and
V11) treated with rapamycin (20 nM, 24 hr) or carbamazepine (100 mM, 24 hr,
following acute DJm depolarization with antimycin A (40 mM) in hippocampal
f both drugs (n > 35 axons per condition from 5–10 experiments).
lic and mitochondria-enriched fractions from cortex of Tsc1cc;Syn1Cre+ mice
re+ littermates (n = 8, post-natal day [P]21).
etreated with rapamycin or carbamazepine (n > 20 axons per condition from >4
+ mice (n = 2), Tsc1cc;Syn1Cre+ mice treated with rapamycin (n = 3), and
roscopy.
reated with rapamycin or carbamazepine (n > 15 axons per condition from 3–5
stable presynaptic puncta supported by mitochondria in hippocampal neurons
or a combination of both drugs (n = 14 axons per condition from 7 experiments).
hippocampal neurons (DIV7/8) pretreated with rapamycin, carbamazepine, or a
5, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure S6.
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et al., 2013; Zheng et al., 2016). Likewise, the mechanisms by
which deficits in the lysosome-dependent stages of mitophagy
are bypassed or corrected upon increased autophagic flux
remain to be investigated in detail.
In summary, our results provide evidence for a role of impaired
neuronal mitophagy in TSC, by showing that mTORC1 hyperac-
tivity impairs the lysosome-dependent stages of mitochondrial
turnover. Our study clarifies the complex relationship between
the TSC-mTORC1 pathway, autophagy, and mitophagy, and
defines mitochondrial homeostasis as a therapeutic target for
TSC and related diseases.
EXPERIMENTAL PROCEDURES
Please see the Supplemental Experimental Procedures for details.
Animals
Tsc1cc;Syn1Cre+ mice were described previously (Meikle et al., 2007). Rapa-
mycin was administered i.p. at 6 mg/kg every other day starting at postnatal
day 7.
Generation of Human iPSC and Cortical Neuron Differentiation
Human iPSCs were generated using episomal plasmids to introduce the
reprogramming factors (Oct4, Sox2, Klf4, and L-Myc) into blood cells or fibro-
blasts (Table S1). Homozygous TSC2mutant iPSC lines were generated using
TALEN-mediated mutagenesis. Cortical neuronal differentiation was adapted
from Zhang et al. (2013).
Live-Cell Confocal Imaging
Confocal images were obtained using a spinning disk confocal microscope
(Perkin Elmer) with a Nikon Ti-Eclipse live cell imaging system and Volocity
software (Perkin Elmer).
Mitochondrial Motility
A mid-axonal compartment (500–800 mm from the soma) was identified, and
images were captured every 3 s. Individual mitochondria were analyzed in
a standardized manner using the custom-written Kymolizer macro in ImageJ
(Pekkurnaz et al., 2014).
Axonal Mitophagy
LC3 and lysosome recruitment to mitochondria was quantified as described in
Ashrafi et al. (2014).
Presynaptic Capturing of Mitochondria
Mitochondrial capturing at synapses was measured as described in Courchet
et al. (2013).
Statistical Analysis
Statistical analysis was performed with GraphPad Prism 6.0 (GraphPad Soft-
ware). Throughout the manuscript, the distribution of data points is expressed
as mean ± SEM. Mann-Whitney U test, unpaired Student t test or one-way
ANOVA with post hoc Bonferroni’s multiple-comparisons test was used to
determine significance. p < 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, one table, and five movies and can be found with this article online
at http://dx.doi.org/10.1016/j.celrep.2016.09.054.
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